75
Participants
Start Date
June 1, 2023
Primary Completion Date
June 1, 2025
Study Completion Date
December 1, 2025
Kenalog with bupivacaine Injection
Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
RECRUITING
Florida Orthopaedic Institute, Tampa
Florida Orthopaedic Institute
NETWORK
Foundation for Orthopaedic Research and Education
OTHER